Visa stock tumbles as “agentic commerce” fears hit payment giants

Visa stock tumbles as “agentic commerce” fears hit payment giants

February 24, 2026

New York, Feb 24, 2026, 10:52 AM EST — Regular session

  • Visa shares slid roughly 4.5% in late morning trading, deepening the sharp decline from Monday.
  • A viral “thought exercise” making the rounds about AI agents and stablecoins has put fresh pressure on card-network fee structures.
  • Investors are eyeing U.S. data releases and forthcoming executive comments, looking for any hint that the selloff might be losing momentum.

Visa Inc dropped roughly 4.5% to $306.52 on Tuesday, caught in a second straight session of selling that pressured payments stocks exposed to consumer spending and transaction fees. Mastercard gave up about 5.7%, while American Express tumbled 7.2% over the same period.

Visa’s model relies on skimming a fraction of every card transaction, multiplied across huge volumes. So when investors even hint at doubts about how long that “toll” can last, shares can swing fast.

The drop traced back to Monday, when payments and delivery names slid across the board. Trigger: a scenario from Citrini Research speculating on AI’s potential to overhaul the economy and reroute transactions.

Here’s the pitch: AI agents—basically, programs that buy things for users—zero in on interchange fees tucked inside most card swipes and start searching for lower-cost rails. “Once agents controlled the transaction, they went looking for bigger paperclips,” the authors note. The logic is stablecoins on Solana or Ethereum layer-2 networks might deliver ultra-fast settlement for a fraction of the cost. Citrini Research

Nerves were already frayed by policy and tech headlines when the report started making waves. “It’s getting a lot of airplay,” said Tony Sycamore, market analyst at IG in Sydney. For Deutsche Bank’s Jim Reid, the “vibes-to-substance ratio” was, in his words, “undeniably high.” MarketScreener

Even so, the catalyst isn’t exactly straightforward. Citrini labels the analysis as “a scenario, not a prediction,” underscoring the gap between this kind of thought exercise and the nuts-and-bolts of real-world payment systems. Regulatory hurdles, merchants’ willingness to get on board, and ingrained consumer behaviors all complicate things. Citrini Research

For Visa, there’s a simpler question in play: is consumer spending cooling off to the point where it dents payment volumes? Last time out, Visa reported that robust card activity pushed both quarterly profit and revenue higher. The company is often used by investors as a barometer for consumer strength and trends in cross-border travel.

Up next: a test on sentiment and incoming numbers. This week’s U.S. consumer-confidence report is in focus, as traders scan for headline risk that could push the “AI disruption” narrative deeper into financials. Nasdaq

Visa is lining up some public appearances aimed at reassuring investors. Chief Product and Strategy Officer Jack Forestell will take the stage first at Morgan Stanley’s Technology, Media & Telecom Conference on March 3, then heads to a Wolfe Research fintech forum on March 11.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Sonic Healthcare (ASX:SHL) Slips Early in 2025, Still Draws Interest on Revenue and Growth
    July 17, 2026, 6:52 PM EDT. Sonic Healthcare Ltd (ASX:SHL) shares dipped 2.5% early in 2025. The stock still gets attention for its footprint in pathology, diagnostics, and medical services worldwide. Healthcare names like SHL see steady business from 'sticky' revenue as patient spending tends to hold up in tough markets. The ASX200 Healthcare Index has lagged behind the wider market but stays steady over time. Outlook for the sector stays solid, with US healthcare spending forecast to climb 7% a year out to 2027. Some areas-healthcare IT and SaaS-are tipped to grow revenue by more than 15%. Ethical money keeps flowing into the space. SHL, with rising sales, trades at 1.21x price-to-sales, below the five-year average of 1.94x. Valuation's not the only call for anyone weighing the shares.